With the Same Extra Set of Genomes, Why Do Cell Fates Diverge?

Cell division may seem like one of life’s most routine tasks, but it is also a moment when errors are most likely to leave long-term consequences. When a cell has already replicated its DNA but ultimately fails to split into two daughter cells, it continues toward its next fate carrying doubled genetic material; this kind of whole-genome doubling has long been viewed as an important clue in aging, cancer, and other diseases.

A study recently published in Proceedings of the National Academy of Sciences attempts to break this question down more finely. The Hokkaido University team compared two routes that cause whole-genome doubling: one in which a cell almost completes division but fails at the final cytokinesis stage; and another in which a cell exits prematurely after entering mitosis, known as mitotic slippage.

On the surface, both produce cells with doubled DNA content. But using live-cell imaging and chromosome-specific labeling to track the cells, the researchers found that the later behavior of these two types of cells was not the same. Cells formed through cytokinesis failure were more stable and more likely to survive; cells produced by mitotic slippage more often showed uneven chromosome distribution and had lower survival rates.

The key appears to lie in how chromosomes align and separate. If sister chromatids are not properly separated, a cell may have doubled DNA, but severe internal genetic imbalance may make it difficult for the cell to persist. Conversely, if chromosome distribution remains broadly balanced, a cell carrying an abnormally doubled genome may still retain relatively high proliferative capacity.

Another intriguing observation in the study was that when the team experimentally improved the chromosome separation state of cells undergoing mitotic slippage, the cells’ ability to survive also increased. This shifts the research focus from “DNA becoming doubled” itself to whether chromosomal order is preserved when doubling occurs; for cancer research, this may help explain why some abnormal cells are not cleared, but instead leave room for later proliferation.

However, this study remains primarily a finding at the level of cellular mechanisms and cannot be directly inferred as a treatment strategy. Whole-genome doubling is common in tumors and may also occur under some treatment pressures, but the human tumor environment is far more complex than cultured cells. The more prudent interpretation at this stage is that even when division failure is the same broad event, differences in the route shape different cellular outcomes; to prevent dangerous cells from surviving, future work may need to see more precisely the moment at which that failure occurs.